INDIANAPOLIS—Indiana University School of Medicine has named a nationally-recognized glaucoma specialist as the new chair of the Department of Ophthalmology.
John T. Lind, MD, MS, has been named the new chair, after serving as interim chair of the department since July 1, 2023. He will be assuming the title of Merrill Grayson Senior Chair in Ophthalmology.
A Bloomington native who completed his undergraduate and medical school studies at Indiana University, Lind joined the faculty at IU School of Medicine in 2019. A glaucoma specialist and board-certified ophthalmologist, he completed his transitional internship at Ascension St. Vincent Hospital in Indianapolis in 2005, and later completed a three-year residency in ophthalmology at Saint Louis University Eye Institute in 2008. That training was followed by a fellowship in glaucoma at the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine in 2009.
“Throughout his career, Dr. Lind has proven himself to be a collaborative and visionary leader dedicated to advancing education, research and clinical care here at the IU School of Medicine,” said Jay L. Hess, MD, PhD, MHSA, dean of IU School of Medicine and Executive Vice President of University Clinical Affairs for IU. “With a reputation for quality improvement and innovative solutions, Dr. Lind’s skillset makes him uniquely qualified to lead the Department of Ophthalmology into what I am confident will be an era of continued growth and excellence.”
After completing his training, Dr. Lind worked as an assistant professor of ophthalmology at Saint Louis University, and later joined the faculty at Washington University School of Medicine in St. Louis as an associate professor. He was selected as Professor of the Year in 2011 at Saint Louis University and again in 2019 at Washington University in Saint Louis. He returned to IU School of Medicine in 2019 to join the faculty with the Department of Ophthalmology.
“I feel very fortunate for having been recruited back to Indiana University over four years ago, and for the leadership opportunities I have been afforded both at IU as well as my previous institutions,” said Lind. “I am thankful for my tremendous colleagues within the department and the university, and I have unwavering confidence in our ability to grow, while enhancing our research, education and clinical care missions.”
Lind’s research interests include glaucoma surgical devices, complications of glaucoma surgery, and medical education. He is a reviewer for the American Journal of Ophthalmology, JAMA Ophthalmology, Journal of Glaucoma, and Journal of Clinical and Experimental Ophthalmology. He was awarded the Achievement Award by the American Academy of Ophthalmology in 2019. He served on the Preferred Practice Patterns Committee for the American Academy of Ophthalmology in 2019, currently serves as a subcommittee member for the Annual Meeting Program Committee for the American Academy of Ophthalmology, and is an examiner and question writer for the American Board of Ophthalmology.
About IU School of Medicine
The IU School of Medicine is the largest medical school in the U.S. and is annually ranked among the top medical schools in the nation by U.S. News & World Report. The school offers high-quality medical education, access to leading medical research and rich campus life in nine Indiana cities, including rural and urban locations consistently recognized for livability. According to the Blue Ridge Institute for Medical Research, the IU School of Medicine ranks No. 13 in 2023 National Institutes of Health funding among all public medical schools in the country.